Table 1.
Gene | Putative gene function | Association with SCD | SNP/mutation | Strength of evidencea | Ref |
---|---|---|---|---|---|
SCN5A | Encodes α subunit of the cardiac voltage-gated sodium channel (Nav1.5) | Variants were associated with SCD | rs7626962 (p.Ser1103Tyr) | ++ | [25] |
rs11720524 | [22] | ||||
rs41312391 | [26] | ||||
KCNH2 | Encodes the Kv11.1 channel that regulates the rapid component of the delayed rectifier potassium current | Variants were associated with SCD | rs199472830 (p.Phe29Leu) | + | [30] |
rs199472882 (p.Pro297Ser) | [30] | ||||
Variants were associated with probable SCD cases | rs199472918 (p.Leu552Ser) | + | [31] | ||
rs36210422 (p.Arg176Trp) | [31] | ||||
KCNQ1 | Encodes the Kv7.1 channel that regulates the slow delayed rectifier current | Variant was associated with SCD | rs120074178 (p.Arg190Trp) | + | [30] |
Variant was associated with an increased risk of SCD | rs2283222 | + | [32] | ||
RYR2 | Encodes calcium channel involved in the regulation of calcium ion release from the sarcoplasmic reticulum | Variant was associated with an increased risk of SCD | rs3766871 (p.Gly1886Ser) | ++ | [23] |
MYBPC3 | Encodes cardiac myosin binding protein C required for normal cardiac function | Variant was associated with an increased risk of SCD | p.F305Pfsa27 | + | [34] |
ACE | Encodes angiotensin converting enzyme that catalyzes the conversion of angiotensin I to angiotensin II and the inactivation of bradykinin via the kallikrein-kininogen system | Variant was associated with an increased risk of SCD | DD genotype or D allele | + | [35] |
PKP2 | Encodes plakophilin 2 which is responsible for linking cadherins to intermediate filaments in the cytoskeleton | Variants were associated with arrhythmia disorder and risk of SCD | Q59L | + | [31] |
Q62K | |||||
N613K | |||||
DSP | Encodes desmoplakin that functions to maintain structure integrity | Variants were associated with sudden unexplained nocturnal death syndrome (SUNDS) | rs188516326 (p.Q90R) | + | [36] |
rs116888866 (p.R2639Q) | |||||
rs200476515 (p.R315C) | |||||
rs569786610 (p.E1357D) | |||||
rs185367490 (p.N1234S) | |||||
rs184154918 (p.R1308Q) | |||||
rs181378432 (p.T2267S) | |||||
novel (p.D2579H) (p.I125F) (p.D521A) |
aStrength of evidence was rated as “+”: weak, “++”: medium and “+++”: strong based on number of published findings supporting significant correlation of a particular biomarker with SCD, sample size and clinical validity